Table 2.
Molecular typing and antimicrobial resistance profile among 81 MRSA isolated from cystic fibrosis patients
| Patient | Isolates (n) | lukS/F (n) | SCCmec (n) | spa type (n) | Antimicrobial resistance profile (n) |
|---|---|---|---|---|---|
| 1 | 12 | Negative (12) | II | t539 (11) | FOX-DA-E-CN-RD-CIP-TE-C (1)a |
| FOX-DA-E-RD-CIP-C (5)a | |||||
| FOX-DA-E-RD-CIP (4)a | |||||
| FOX-DA-E-CIP-C (1)a | |||||
| IV | t002 (1) | FOX-E-CIP-C (1) | |||
| 2 | 7 | Negative (4) | IV | t002 (4) | FOX-DA-E-RD (1)a |
| FOX-E-CIP (1) | |||||
| FOX-E (2) | |||||
| Positive (2) Negative (1) |
t18 066 (3) | FOX (3) | |||
| 3 | 3 | Negative (3) | IV | t021(3) | FOX-DA (1) |
| FOX (2) | |||||
| 4 | 5 | Positive (3) Negative (2) |
IV | t1605 (5) | FOX-CIP (2) |
| FOX (3) | |||||
| 5 | 13 | Negative (13) | IV | t002 (6) | FOX-DA-E-RD (1)a |
| FOX-E-CIP (1) | |||||
| FOX-E (2) | |||||
| FOX (2) | |||||
| III | t779 (7) | FOX-DA-E-CN-RD-CIP-TE-SXT-C (2)a | |||
| FOX-DA-E-CN-RD-CIP-TE-SXT (3)a | |||||
| FOX-DA-E-CN-CIP-TE-SXT-C (1)a | |||||
| FOX-DA-E-CN-CIP-TE-SXT (1)a | |||||
| 6 | 7 | Negative (7) | IV | t002 (5) | FOX-DA-E-CIP (1)a |
| FOX-E-CIP (1) | |||||
| FOX-E (3) | |||||
| II | t8784 (2) | FOX-DA-E-CIP-C (2)a | |||
| 7 | 8 | Positive (1) Negative (3) |
IV | t002 (4) | FOX-E-CIP (1) |
| FOX-E (3) | |||||
| Negative (4) | t1154 (4) | FOX-E-CIP (1) | |||
| FOX-E-C (1) | |||||
| FOX-E (2) | |||||
| 8 | 7 | Negative (7) | IV | t002 (6) | FOX-E-CN-CIP-C (1)a |
| FOX-E-CN-CIP (3)a | |||||
| FOX-CN-CIP (1) | |||||
| FOX-CIP (1) | |||||
| II | t539 (1) | FOX-DA-E-RD-CIP (1)a | |||
| 9 | 5 | Negative (3) | IV | t002 (3) | FOX-E (1) |
| FOX (2) | |||||
| Positive (1) | t318 (1) | FOX (1) | |||
| Negative (1) | t1154 (1) | FOX-E (1) | |||
| 10 | 3 | Negative (3) | IV | t002 (3) | FOX-DA-E-RD-CIP-C (1)a |
| FOX-E (2) | |||||
| 11 | 3 | Negative (3) | IV | t002 (3) | FOX-E-CIP (1) |
| FOX-E (2) | |||||
| 12 | 8 | Negative (8) | IV | t002 (8) | FOX-DA-E-CIP (1) |
| FOX-E-CIP (3) | |||||
| FOX-E (4) |
FOX, cefoxitin; C, chloramphenicol; CIP, ciprofloxacin; DA, clindamycin; E, erythromycin; CN, gentamicin; LZD, linezolid; RD, rifampin; SXT, sulfamethoxazole-trimethoprim; TE, tetracycline.
a
Multidrug resistance (MDR).